Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triflusal for cognitive function in chronic stress
NCT02904109Phase 2Completed
- Start
- Sep 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Triflusal in chronic stress (2 arms). Primary endpoint: Change in performance in episodic memory task as assessed by a verbal memory task. Started Sep 2016; status: completed.
02
Drugs
Triflusal
03
Conditions
chronic stress
Beyond the preview
Go deeper on NCT02904109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02904109.